［Abstract］　Severe trauma is the main cause of death and disability, causing up to 8 million deaths worldwide every year, and traumatic hemorrhage is the leading cause of death among the injured persons. At present, there is still a lack of feasible standard of blood resuscitation for traumatic hemorrhage in China, which affects the prognosis of the injured persons. For this reason, the Working Party on Clinical Transfusion, Chinese Society of Blood Transfusion has formulated expert consensus on patient blood management for traumatic hemorrhage(2022 edition), emphasizing that patient blood management for traumatic hemorrhage must be based on correct damage control resuscitation, and the management of platelets and coagulation factors must be paid attention to. This expert consensus establishes a practical massive transfusion protocol for traumatic hemorrhage patients.]]> 2022/7/4 0:00:00 Working Party on Clinical Transfusion, Chinese Society of Blood Transfusion 4true ［Abstract］　Postpartum hemorrhage(PPH) is an obstetric critical illness that requires patient blood management(PBM) to improve the patients′ prognosis. Based on this understanding, the Working Party on Clinical Transfusion, Chinese Society of Blood Transfusion(CSBT) has formulated an expert consensus on PBM for PPH. The consensus emphasizes that PBM must be based on the correct treatment of PPH. The consensus emphasizes the management of the function and quantity of platelets and coagulation factors, and defines the indications for transfusion of platelets and fresh frozen plasma in various situations. The consensus also clearly proposes ways to implement massive transfusion protocol.]]> 2022/1/29 11:54:58 Working Party on Clinical Transfusion, Chinese Society of Blood Transfusion(CSBT) 3true ［Abstract］　Transfusion-associated graft-versus-host disease(TA-GVHD) is a rare but extremely serious complication of blood transfusion. The Editorial Committee of Expert Consensus on the Clinical Diagnosis and Treatment of Transfusion-Associated Graft-versus-Host Disease(2025 Edition) organized the experts in China from the fields of blood transfusion department, hematology department and digestive department to formulate Expert Consensus on the Clinical Diagnosis and Treatment of Transfusion-Associated Graft-versus-Host Disease(2025 Edition). This consensus puts forward expert consensus opinions on the auxiliary examinations related to TA-GVHD, the diagnosis and differential diagnosis of TA-GVHD, and the prevention and treatment strategies of TA-GVHD.]]> 2025/7/31 0:00:00 The Editorial Committee of Expert Consensus on the Clinical Diagnosis and Treatment of Transfusion-Associated Graft-versus-Host Disease(2025 Edition)]]> The Editorial Committee of Expert Consensus on the Clinical Diagnosis and Treatment of Transfusion-Associated Graft-versus-Host Disease(2025 Edition) 2true ［Abstract］　Chylous ascites is a rare but serious complication after lymph node resection for gynecological malignancies. Its occurrence is closely related to high-level para-aortic lymph node resection, laparoscopic operation and perioperative malnutrition. Clinical diagnosis of chylous ascites requires a combination of criteria such as a chylous fluid drainage volume ≥200 mL/d and a triglyceride level exceeding 200 mg/dL in the fluid. A stepwise therapeutic approach is recommended: conservative management(dietary modification combined with pharmacological therapy) as the first-line treatment, followed by lymphangiography in or in no combination with embolization for the patients who have failed to respond to the conservative treatment, and surgical ligation or lymphovenous anastomosis for refractory cases. The consensus emphasizes preventing chylous ascites through comprehensive measures such as meticulous intraoperative operations, the application of biological agents, and delayed extubation after surgery. The formulation of this consensus provides an evidence-based foundation for the standardized clinical management of chylous ascites after lymphadenectomy for gynecological malignancies.]]> 2025/10/31 10:05:06 Chinese Anti-Cancer Association Committee for Integrative Traditional Chinese-Western Medicine in Ovarian Cancer, Obstetrics and Gynecology Branch of Guangxi Medical Association 1true